Report Detail

Other Global Insulin Drug Delivery Devices Market Growth 2019-2024

  • RnM2837340
  • |
  • 29 January, 2019
  • |
  • Global
  • |
  • 136 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.

According to this study, over the next five years the Insulin Drug Delivery Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin Drug Delivery Devices business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

This study considers the Insulin Drug Delivery Devices value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Homecare
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Insulin Drug Delivery Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Insulin Drug Delivery Devices market by identifying its various subsegments.
Focuses on the key global Insulin Drug Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin Drug Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin Drug Delivery Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Insulin Drug Delivery Devices Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Insulin Drug Delivery Devices Consumption 2014-2024
        • 2.1.2 Insulin Drug Delivery Devices Consumption CAGR by Region
      • 2.2 Insulin Drug Delivery Devices Segment by Type
        • 2.2.1 Syringes
        • 2.2.2 Insulin Pens
        • 2.2.3 Jet Injectors
        • 2.2.4 Insulin Pumps
      • 2.3 Insulin Drug Delivery Devices Consumption by Type
        • 2.3.1 Global Insulin Drug Delivery Devices Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Insulin Drug Delivery Devices Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Insulin Drug Delivery Devices Sale Price by Type (2014-2019)
      • 2.4 Insulin Drug Delivery Devices Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Homecare
        • 2.4.4 Others
      • 2.5 Insulin Drug Delivery Devices Consumption by Application
        • 2.5.1 Global Insulin Drug Delivery Devices Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Insulin Drug Delivery Devices Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Insulin Drug Delivery Devices Sale Price by Application (2014-2019)

      3 Global Insulin Drug Delivery Devices by Players

      • 3.1 Global Insulin Drug Delivery Devices Sales Market Share by Players
        • 3.1.1 Global Insulin Drug Delivery Devices Sales by Players (2017-2019)
        • 3.1.2 Global Insulin Drug Delivery Devices Sales Market Share by Players (2017-2019)
      • 3.2 Global Insulin Drug Delivery Devices Revenue Market Share by Players
        • 3.2.1 Global Insulin Drug Delivery Devices Revenue by Players (2017-2019)
        • 3.2.2 Global Insulin Drug Delivery Devices Revenue Market Share by Players (2017-2019)
      • 3.3 Global Insulin Drug Delivery Devices Sale Price by Players
      • 3.4 Global Insulin Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Insulin Drug Delivery Devices Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Insulin Drug Delivery Devices Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Insulin Drug Delivery Devices by Regions

      • 4.1 Insulin Drug Delivery Devices by Regions
        • 4.1.1 Global Insulin Drug Delivery Devices Consumption by Regions
        • 4.1.2 Global Insulin Drug Delivery Devices Value by Regions
      • 4.2 Americas Insulin Drug Delivery Devices Consumption Growth
      • 4.3 APAC Insulin Drug Delivery Devices Consumption Growth
      • 4.4 Europe Insulin Drug Delivery Devices Consumption Growth
      • 4.5 Middle East & Africa Insulin Drug Delivery Devices Consumption Growth

      5 Americas

      • 5.1 Americas Insulin Drug Delivery Devices Consumption by Countries
        • 5.1.1 Americas Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
        • 5.1.2 Americas Insulin Drug Delivery Devices Value by Countries (2014-2019)
      • 5.2 Americas Insulin Drug Delivery Devices Consumption by Type
      • 5.3 Americas Insulin Drug Delivery Devices Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Insulin Drug Delivery Devices Consumption by Countries
        • 6.1.1 APAC Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
        • 6.1.2 APAC Insulin Drug Delivery Devices Value by Countries (2014-2019)
      • 6.2 APAC Insulin Drug Delivery Devices Consumption by Type
      • 6.3 APAC Insulin Drug Delivery Devices Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Insulin Drug Delivery Devices by Countries
        • 7.1.1 Europe Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
        • 7.1.2 Europe Insulin Drug Delivery Devices Value by Countries (2014-2019)
      • 7.2 Europe Insulin Drug Delivery Devices Consumption by Type
      • 7.3 Europe Insulin Drug Delivery Devices Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Insulin Drug Delivery Devices by Countries
        • 8.1.1 Middle East & Africa Insulin Drug Delivery Devices Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Insulin Drug Delivery Devices Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Insulin Drug Delivery Devices Consumption by Type
      • 8.3 Middle East & Africa Insulin Drug Delivery Devices Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Insulin Drug Delivery Devices Distributors
      • 10.3 Insulin Drug Delivery Devices Customer

      11 Global Insulin Drug Delivery Devices Market Forecast

      • 11.1 Global Insulin Drug Delivery Devices Consumption Forecast (2019-2024)
      • 11.2 Global Insulin Drug Delivery Devices Forecast by Regions
        • 11.2.1 Global Insulin Drug Delivery Devices Forecast by Regions (2019-2024)
        • 11.2.2 Global Insulin Drug Delivery Devices Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Insulin Drug Delivery Devices Forecast by Type
      • 11.8 Global Insulin Drug Delivery Devices Forecast by Application

      12 Key Players Analysis

      • 12.1 Novo Nordisk
        • 12.1.1 Company Details
        • 12.1.2 Insulin Drug Delivery Devices Product Offered
        • 12.1.3 Novo Nordisk Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Novo Nordisk News
      • 12.2 Sanofi
        • 12.2.1 Company Details
        • 12.2.2 Insulin Drug Delivery Devices Product Offered
        • 12.2.3 Sanofi Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Sanofi News
      • 12.3 BD
        • 12.3.1 Company Details
        • 12.3.2 Insulin Drug Delivery Devices Product Offered
        • 12.3.3 BD Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 BD News
      • 12.4 Eli Lilly
        • 12.4.1 Company Details
        • 12.4.2 Insulin Drug Delivery Devices Product Offered
        • 12.4.3 Eli Lilly Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Eli Lilly News
      • 12.5 Medtronic
        • 12.5.1 Company Details
        • 12.5.2 Insulin Drug Delivery Devices Product Offered
        • 12.5.3 Medtronic Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Medtronic News
      • 12.6 Beta Bionics
        • 12.6.1 Company Details
        • 12.6.2 Insulin Drug Delivery Devices Product Offered
        • 12.6.3 Beta Bionics Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Beta Bionics News
      • 12.7 Dance Biopharm
        • 12.7.1 Company Details
        • 12.7.2 Insulin Drug Delivery Devices Product Offered
        • 12.7.3 Dance Biopharm Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Dance Biopharm News
      • 12.8 Roche
        • 12.8.1 Company Details
        • 12.8.2 Insulin Drug Delivery Devices Product Offered
        • 12.8.3 Roche Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Roche News
      • 12.9 Tandem Diabetes Care
        • 12.9.1 Company Details
        • 12.9.2 Insulin Drug Delivery Devices Product Offered
        • 12.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Tandem Diabetes Care News
      • 12.10 Animas
        • 12.10.1 Company Details
        • 12.10.2 Insulin Drug Delivery Devices Product Offered
        • 12.10.3 Animas Insulin Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Animas News

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Insulin Drug Delivery Devices . Industry analysis & Market Report on Insulin Drug Delivery Devices is a syndicated market report, published as Global Insulin Drug Delivery Devices Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Insulin Drug Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,829.18
      4,243.77
      5,658.36
      3,407.46
      5,111.19
      6,814.92
      558,845.40
      838,268.10
      1,117,690.80
      308,904.00
      463,356.00
      617,808.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report